Ruben Alberto Tommasi,Michael David Shultz,Leslie Wighton McQuire,Pascal Rigollier,Olivier Rogel,Claus Ehrhardt
申请号：
US13690274
公开号：
US20130096105A1
申请日:
2012.11.30
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention provides a compound of formula (I):said compound is inhibitor of MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12 and/or MMP-13, and thus can be employed for the treatment of a disorder or disease characterized by abnormal activity of MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12 and/or MMP-13. Accordingly, the compound of formula (I) can be used in treatment of disorders or diseases mediated by MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12, and/or MMP-13. Finally, the present invention also provides a pharmaceutical composition.
